Showing results (2371-2380 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|March 8, 2023
Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic ReviewOlena Mandrik, Anne I Hahn, James W F Catto, et al.Pharmacoeconomics|June 7, 2015
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International ReviewBonny Parkinson, Catherine Sermet, Fiona Clement, et al.Pharmacoeconomics|August 3, 2016
Vedolizumab for Treating Moderately to Severely Active Crohn's Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachid Rafia, Alison Scope, Sue Harnan, et al.Pharmacoeconomics|August 27, 2021
Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSabine E Grimm, Ben Wijnen, Rob Riemsma, et al.Pharmacoeconomics|September 4, 2021
The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing-Remitting Multiple SclerosisLaurenske A Visser, Marc Folcher, Claudia Delgado Simao, et al.Pharmacoeconomics|May 7, 2021
Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of InterestStephanie Harvard, Gregory R WerkerPharmacoeconomics|May 27, 2020
Financing Drug Innovation in the US: Current Framework and Emerging ChallengesDavid Cutler, Noam Kirson, Genia LongPharmacoeconomics|June 14, 2020
Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the USWilliam V Padula, Sonal Parasrampuria, Mariana P Socal, et al.Pharmacoeconomics|June 10, 2020
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBen Wijnen, Nigel Armstrong, Bram Ramaekers, et al.Pharmacoeconomics|August 12, 2022
Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic ReviewSuzana Karim, Benjamin M Craig, Caroline Vass, et al.Pageof 336